Lexaria Bioscience LEXX
NASDAQ LEXX
$2.88 -0.21 (-6.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Income from Discontinued Operations (2019 - 2021)

Updated

Lexaria Bioscience (LEXX) reported Income from Discontinued Operations of -$44,000 for fiscal Q4 2021 (quarter ended Aug 31, 2021), compared with -$19,611 a year earlier.

Analysis

Lexaria Bioscience (LEXX) Income from Discontinued Operations (2019 - 2021) Analysis & Trends

For FY2021 (ended Aug 31, 2021), Lexaria Bioscience posted Income from Discontinued Operations of -$22,000.

  • By fiscal year, Income from Discontinued Operations came in at $64,184 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Lexaria Bioscience 3.04 Mn -12.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 -44,000.00
Feb 28, 2021 -25,000.00
Nov 30, 2020 3,000.00
Aug 31, 2020 -19,611.00
May 31, 2020 19,611.00
Feb 29, 2020 64,184.00
Nov 30, 2019 51,344.00
API Access

Lexaria Bioscience Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=LEXX&period=max&api_key=YOUR_API_KEY